Susan Sweeney spent more than two decades in drug commercialization at Bristol Myers Squibb before moving to Amgen in September 2019, just a few months before the Covid-19 pandemic. Sweeney, now Amgen’s senior VP of global marketing, access and capabilities, didn’t know of course what was about to happen any…
…
